| Literature DB >> 35682916 |
Valeria Gigli1, Davide Piccinino2, Daniele Avitabile3, Riccarda Antiochia4, Eliana Capecchi2, Raffaele Saladino2.
Abstract
The overproduction of eumelanin leads to a panel of unaesthetic hyper-pigmented skin diseases, including melasma and age spots. The treatment of these diseases often requires the use of tyrosinase inhibitors, which act as skin whitening agents by inhibiting the synthesis of eumelanin, with harmful side effects. We report here that laccase from Trametes versicolor in association with a cocktail of natural phenol redox mediators efficiently degraded eumelanin from Sepia officinalis, offering an alternative procedure to traditional whitening agents. Redox mediators showed a synergistic effect with respect to their single-mediator counterpart, highlighting the beneficial role of the cocktail system. The pro-oxidant DHICA sub-units of eumelanin were degraded better than the DHI counterpart, as monitored by the formation of pyrrole-2,3,5-tricarboxylic acid (PTCA) and pyrrole-2,3-dicarboxylic acid (PDCA) degradation products. The most effective laccase-mediated cocktail system was successively applied in a two-component prototype of a topical whitening cream, showing high degradative efficacy against eumelanin.Entities:
Keywords: eumelanin decolorization; laccase mediator cocktail system; skin whitening agents
Mesh:
Substances:
Year: 2022 PMID: 35682916 PMCID: PMC9181290 DOI: 10.3390/ijms23116238
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Decolorization efficiency of eumelanin by LMS at different amounts of mediators (0.4, 0.8, and 1.6 μmol).
| Entry | LMS | μmol | DE% |
|---|---|---|---|
| 1 | ABTS | (0.4) (0.8)(1.6) | (10) 1 (18) 2 (26) 3 |
| 2 | TEMPO | (0.4) (0.8) (1.6) | (20) 1 (21) 2 (16) 3 |
| 3 | V | (0.4) (0.8)(1.6) | (12) 1 (13) 2 (36) 3 |
| 4 | Syr | (0.4) (0.8) (1.6) | (17) 1 (25) 2 (10) 3 |
| 5 | As | (0.4) (0.8) (1.6) | (16) 1 (9) 2 (9) 3 |
| 6 | Av | (0.4) (0.8) (1.6) | (8) 1 (14) 2 (16) 3 |
| 7 | Va | (0.4) (0.8) (1.6) | (15) 1 (16) 2 (28) 3 |
1 Percentage of decolorization efficiency (DE%) calculated after 4 h of reaction at amount of mediators of 0.4 μmol. 2 DE% after 4 h at amount of mediators of 0.8 μmol. 3 DE% after 4 h at amount of mediators of 1.6 μmol.
Eumelanin decolorization with LMCS in different molar concentration ratios and at different reaction times (4 h, 24 h, and 48 h).
| Entry | LMCS | Molar Ratio 1 | DE%(4 h) 2 | DE%(24 h) 2 | DE%(48 h) 2 |
|---|---|---|---|---|---|
| 1 | ABTS/V | 0.5:1 | 15 | - | - |
| 2 | ABTS/V | 1:1 | 50 | 70 (76) 3 | 67 |
| 3 | ABTS/V | 2:1 | 18 | - | - |
| 4 | TEMPO/V | 0.5:1 | 22 | - | - |
| 5 | TEMPO/V | 1:1 | 46 | 63 (76) 3 | 66 |
| 6 | TEMPO/V | 2:1 | 26 | - | - |
| 7 | Syr/V | 0.5:1 | 24 | - | - |
| 8 | Syr/V | 1:1 | 55 | 67 (78) 3 | 67 |
| 9 | Syr/V | 2:1 | 28 | - | - |
| 10 | As/V | 0.5:1 | 19 | - | - |
| 11 | As/V | 1:1 | 39 | 51 (61) 3 | 69 |
| 12 | As/V | 2:1 | 12 | - | - |
| 13 | Av/V | 0.5:1 | 12 | - | - |
| 14 | Av/V | 1:1 | 31 | 46 | 47 |
| 15 | Av/V | 2:1 | 14 | - | - |
| 16 | Va/V | 0.5:1 | 28 | - | - |
| 17 | Va/V | 1:1 | 67 | 87 (96) 3 | 71 |
| 18 | Va/V | 2:1 | 32 | - | - |
| 19 | As/Av | 0.5:1 | 15 | - | - |
| 20 | As/Av | 1:1 | 34 | 38 | 38 |
| 21 | As/Av | 2:1 | 10 | - | - |
| 22 | Av/Syr | 0.5:1 | 2 | - | - |
| 23 | Av/Syr | 1:1 | 3 | 9 | 6 |
| 24 | Av/Syr | 2:1 | 1 | - | - |
| 25 | As/Syr | 0.5:1 | 8 | - | - |
| 26 | As/Syr | 1:1 | 16 | 28 | 38 |
| 27 | As/Syr | 2:1 | 11 | - | - |
1 Ratio applied in order to reach a total amount of 1.6 μmol of redox mediators. 2 Percentage of decolorization efficiency calculated after 4 h, 24 h, and 48 h of reaction. 3 DE% calculated after the second cycle of LMCS, expressed as total value of DE% obtained after the two treatments (referred to the initial mg of melanin).
Figure 1Comparison of the color intensity of eumelanin after treatment with LMCS at 24 h: (A) Sepia melanin as reference; (B) LMCS As/V; (C) LMCS TEMPO/V; (D) LMCS Syr/V; (E) LMCS ABTS/V; (F) LMCS V/Va.
Amount of PDCA and PTCA recovered after treatment of eumelanin with LMCS.
| Entry | LMCS | PTCA | PDCA | Ratio |
|---|---|---|---|---|
| 1 | ABTS/V | 26.16 | 12.72 | 2.05 |
| 2 | TEMPO/V | 21.47 | 9.40 | 2.28 |
| 3 | Syr/V | 11.12 | 8.92 | 1.25 |
| 4 | As/V | 21.52 | 18.70 | 1.15 |
| 5 | Va/V | 6.11 | 5.14 | 1.18 |
Figure 2FE-SEM images of sepia melanin after LMCS treatments. Panel (A): native sepia melanin. Panel (B): sepia melanin after treatment with LMCS ABTS/V. Panel (C): sepia melanin after treatment with LMCS TEMPO/V. Panel (D): sepia melanin after treatment with LMCS Syr/V. Panel (E): sepia melanin after treatment with LMCS AS/V. Panel (F): sepia melanin after treatment with LMCS Va/V.
Figure 3Attenuated total reflectance Fourier Transform Infrared spectroscopy (ATR-FTIR) of residual sepia melanin after LMCS treatment with ABTS/V (blue line), TEMPO/V (orange line), Syr/V (pink line), As/V (blue line), and Va/V (red line). Original Sepia melanin (green line) is reported as a reference.
Figure 4Panel (a): selected 6X formulation. Panel (b): application of the whitening cream 6X.